Zhejiang Dayang Biotech Group Co Cash Flow Conversion Efficiency

Latest as of September 2025: 0.001x

Zhejiang Dayang Biotech Group Co cash flow conversion efficiency. Based on the latest financial reports, Zhejiang Dayang Biotech Group Co (003017) has a cash flow conversion efficiency ratio of 0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥638.25K ≈ $93.40K USD) by net assets (CN¥1.10 Billion ≈ $161.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Zhejiang Dayang Biotech Group Co (2013–2025)

Cash flow conversion efficiency of Zhejiang Dayang Biotech Group Co from 2013 to 2025. This chart illustrates how Zhejiang Dayang Biotech Group Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 003017 stock price for real-time trading data and today's change.

Zhejiang Dayang Biotech Group Co Cash Flow Conversion Ratio Explained

Zhejiang Dayang Biotech Group Co cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Zhejiang Dayang Biotech Group Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Dayang Biotech Group Co ranked by their cash flow conversion efficiency. Also see how much is Zhejiang Dayang Biotech Group Co worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Shifeng Cultural Development Co Ltd SHE:002862	0.031x
Jiangsu Tongda Power Technology Co Ltd SHE:002576	0.007x
Shenzhen Mingdiao Decoration Co Ltd SHE:002830	0.045x
Dezhou United Petroleum Technology Co.Ltd. SHE:301158	0.014x
Sangam (India) Limited NSE:SANGAMIND	0.009x
Guangzhou Improve Med Instrument SHE:300030	0.104x
Teqnion AB ST:TEQ	0.039x
Ve Wong Corp TW:1203	0.018x

Annual Cash Flow Conversion Efficiency for Zhejiang Dayang Biotech Group Co (2013–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Dayang Biotech Group Co from 2013 to 2025. Review cash generation quality of Zhejiang Dayang Biotech Group Co to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.14 Billion ≈ $166.34 Million	CN¥160.11 Million ≈ $23.43 Million	0.141x	+124.09%
2024-12-31	CN¥1.05 Billion ≈ $154.11 Million	CN¥66.19 Million ≈ $9.69 Million	0.063x	-65.26%
2023-12-31	CN¥1.01 Billion ≈ $147.53 Million	CN¥182.42 Million ≈ $26.69 Million	0.181x	+93.97%
2022-12-31	CN¥985.05 Million ≈ $144.14 Million	CN¥91.89 Million ≈ $13.45 Million	0.093x	+362.87%
2021-12-31	CN¥990.71 Million ≈ $144.97 Million	CN¥-35.16 Million ≈ $-5.14 Million	-0.035x	-130.23%
2020-12-31	CN¥958.13 Million ≈ $140.20 Million	CN¥112.49 Million ≈ $16.46 Million	0.117x	-48.29%
2019-12-31	CN¥498.09 Million ≈ $72.89 Million	CN¥113.09 Million ≈ $16.55 Million	0.227x	+158.02%
2018-12-31	CN¥440.62 Million ≈ $64.48 Million	CN¥38.77 Million ≈ $5.67 Million	0.088x	-38.90%
2017-12-31	CN¥337.71 Million ≈ $49.42 Million	CN¥48.64 Million ≈ $7.12 Million	0.144x	-60.97%
2016-12-31	CN¥229.35 Million ≈ $33.56 Million	CN¥84.63 Million ≈ $12.38 Million	0.369x	+58.13%
2015-12-31	CN¥209.76 Million ≈ $30.70 Million	CN¥48.95 Million ≈ $7.16 Million	0.233x	-20.42%
2014-12-31	CN¥196.87 Million ≈ $28.81 Million	CN¥57.73 Million ≈ $8.45 Million	0.293x	-40.03%
2013-12-31	CN¥187.42 Million ≈ $27.43 Million	CN¥91.64 Million ≈ $13.41 Million	0.489x	--

About Zhejiang Dayang Biotech Group Co

SHE:003017 China Chemicals

Market Cap

$332.62 Million

CN¥2.27 Billion CNY

Market Cap Rank

#14005 Global

#4132 in China

Share Price

CN¥22.55

Change (1 day)

+5.67%

52-Week Range

CN¥19.40 - CN¥34.39

All Time High

CN¥39.37